This compound is a pharmaceutical intermediate featuring a cyclobutane-diamine core substituted with a methyl group and a pyrrolopyrimidine heterocyclic ring. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Despropanesulfonyl Abrocitinib
pharmaceutical intermediate
2-acetyl-2-azabicyclo[2.2.1]hept-5-en-3-one
pharmaceutical intermediate
Bis(2-(7-methoxynaphthalen-1-yl)ethyl)aminehydrochloride
pharmaceutical intermediate
2,4-Dichlorothieno[3,2-d]pyrimidine
pharmaceutical intermediate
N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide
pharmaceutical intermediate
(1s,3s)-N-hydroxy-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutanecarboxamide
research compound
Abrocitinib
pharmaceutical raw material
1-N-methyl-1-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)cyclobutane-1,3-diamine
DSZFXAFWOBUIFN-UHFFFAOYSA-N
CN(C1CC(C1)N)C2=NC=NC3=C2C=CN3
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.